Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes an acute respiratory tract infection known as coronavirus disease 2019 (COVID-19). SARS-CoV-2 enters cells by binding the ACE2 receptor and coreceptors notably TMPRSS2 or Cathepsin L. Severe COVID-19 infection can lead to acute lung injury. Below we describe the current evidence of the impact of common chronic lung diseases (CLDs) on the development of COVID-19. The impact of treatment of CLD on COVID-19 and any risk of vaccination in patients with CLD are considered. Copyright © 2022 Elsevier Inc. All rights reserved.

Citation

Jessica Fae Calver, Laura Fabbri, James May, R Gisli Jenkins. COVID-19 in Patients with Chronic Lung Disease. Clinics in chest medicine. 2023 Jun;44(2):385-393

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 37085227

View Full Text